BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19137297)

  • 1. Allelic genotyping reveals a hierarchy of genomic alterations in mantle cell lymphoma associated to cell proliferation.
    Hutter G; Scheubner M; Ott G; Zimmermann Y; Hübler K; Roth S; Stilgenbauer S; Kalla J; Stöcklein H; Hiddemann W; Dreyling M
    Ann Hematol; 2009 Sep; 88(9):821-8. PubMed ID: 19137297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of epigenetic alterations and genomic deletions of CDK inhibitors [p16(INK4a), p15(INK4b), p14(ARF)] in mantle cell lymphoma.
    Hutter G; Scheubner M; Zimmermann Y; Kalla J; Katzenberger T; Hübler K; Roth S; Hiddemann W; Ott G; Dreyling M
    Genes Chromosomes Cancer; 2006 Feb; 45(2):203-10. PubMed ID: 16258956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma.
    Espinet B; Salaverria I; Beà S; Ruiz-Xivillé N; Balagué O; Salido M; Costa D; Carreras J; Rodríguez-Vicente AE; Luís García J; Hernández-Rivas JM; Calasanz MJ; Siebert R; Ferrer A; Salar A; Carrió A; Polo N; García-Marco JA; Domingo A; González-Barca E; Romagosa V; Marugán I; López-Guillermo A; Millá F; Luís Mate J; Luño E; Sanzo C; Collado R; Oliver I; Monzó S; Palacín A; González T; Sant F; Salinas R; Ardanaz MT; Font L; Escoda L; Florensa L; Serrano S; Campo E; Solé F
    Genes Chromosomes Cancer; 2010 May; 49(5):439-51. PubMed ID: 20143418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes.
    de Leeuw RJ; Davies JJ; Rosenwald A; Bebb G; Gascoyne RD; Dyer MJ; Staudt LM; Martinez-Climent JA; Lam WL
    Hum Mol Genet; 2004 Sep; 13(17):1827-37. PubMed ID: 15229187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-resolution genomic screening in mantle cell lymphoma--specific changes correlate with genomic complexity, the proliferation signature and survival.
    Halldórsdóttir AM; Sander B; Göransson H; Isaksson A; Kimby E; Mansouri M; Rosenquist R; Ehrencrona H
    Genes Chromosomes Cancer; 2011 Feb; 50(2):113-21. PubMed ID: 21117067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations.
    Sander S; Bullinger L; Leupolt E; Benner A; Kienle D; Katzenberger T; Kalla J; Ott G; Müller-Hermelink HK; Barth TF; Möller P; Lichter P; Döhner H; Stilgenbauer S
    Haematologica; 2008 May; 93(5):680-7. PubMed ID: 18367489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of mantle-cell lymphoma: all oncogenic roads lead to dysregulation of cell cycle and DNA damage response pathways.
    Fernàndez V; Hartmann E; Ott G; Campo E; Rosenwald A
    J Clin Oncol; 2005 Sep; 23(26):6364-9. PubMed ID: 16155021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delineation of distinct tumour profiles in mantle cell lymphoma by detailed cytogenetic, interphase genetic and morphological analysis.
    Katzenberger T; Kienle D; Stilgenbauer S; Höller S; Schilling C; Mäder U; Puppe B; Petzoldt C; Sander S; Bullinger L; Stöcklein H; Kalla J; Hartmann E; Adam P; Ott MM; Müller-Hermelink HK; Rosenwald A; Ott G
    Br J Haematol; 2008 Aug; 142(4):538-50. PubMed ID: 18564361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques.
    Salaverria I; Espinet B; Carrió A; Costa D; Astier L; Slotta-Huspenina J; Quintanilla-Martinez L; Fend F; Solé F; Colomer D; Serrano S; Miró R; Beà S; Campo E
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1086-97. PubMed ID: 18709664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes.
    Schraders M; Jares P; Bea S; Schoenmakers EF; van Krieken JH; Campo E; Groenen PJ
    Br J Haematol; 2008 Oct; 143(2):210-21. PubMed ID: 18699851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cytogenetics of mantle cell lymphoma].
    Obukhova TN; Lorie IuIu; Vodinskaia LA; Alimova GA; Nikitin EA; Samoĭlova RS; Kaplanskaia IB; Domracheva EV
    Ter Arkh; 2004; 76(7):70-7. PubMed ID: 15379132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The complex landscape of genetic alterations in mantle cell lymphoma.
    Royo C; Salaverria I; Hartmann EM; Rosenwald A; Campo E; Beà S
    Semin Cancer Biol; 2011 Nov; 21(5):322-34. PubMed ID: 21945515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression, chromosomal alterations, and immunoglobulin variable heavy chain hypermutations in Mantle cell lymphomas.
    Navarro A; Beà S; Fernández V; Prieto M; Salaverria I; Jares P; Hartmann E; Mozos A; López-Guillermo A; Villamor N; Colomer D; Puig X; Ott G; Solé F; Serrano S; Rosenwald A; Campo E; Hernández L
    Cancer Res; 2009 Sep; 69(17):7071-8. PubMed ID: 19690137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of mono-allelic chromosomal aberrations 3' and 5' of the cyclin D1 gene in mantle cell lymphoma using DNA fiber fluorescence in situ hybridization.
    de Boer CJ; Vaandrager JW; van Krieken JH; Holmes Z; Kluin PM; Schuuring E
    Oncogene; 1997 Sep; 15(13):1599-603. PubMed ID: 9380412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH.
    Parry-Jones N; Matutes E; Morilla R; Brito-Babapulle V; Wotherspoon A; Swansbury GJ; Catovsky D
    Br J Haematol; 2007 Apr; 137(2):117-24. PubMed ID: 17391491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis.
    Ek S; Björck E; Porwit-MacDonald A; Nordenskjöld M; Borrebaeck CA
    Haematologica; 2004 Jun; 89(6):686-95. PubMed ID: 15194536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic imbalances and patterns of karyotypic variability in mantle-cell lymphoma cell lines.
    Camps J; Salaverria I; Garcia MJ; Prat E; Beà S; Pole JC; Hernández L; Del Rey J; Cigudosa JC; Bernués M; Caldas C; Colomer D; Miró R; Campo E
    Leuk Res; 2006 Aug; 30(8):923-34. PubMed ID: 16448697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunophenotypic and genetic characterization of a CD8 positive mantle cell lymphoma in a patient with concomitant Mycosis fungoides.
    Schroers R; Hildebrandt Y; Steffens R; Becker S; Ohms G; von Bonin F; Haase D; Bertsch HP; Trümper L; Griesinger F
    Eur J Haematol; 2005 Jul; 75(1):78-84. PubMed ID: 15946316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary chromosome changes in mantle cell lymphoma.
    Wlodarska I; Pittaluga S; Hagemeijer A; De Wolf-Peeters C; Van Den Berghe H
    Haematologica; 1999 Jul; 84(7):594-9. PubMed ID: 10406899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature.
    Salaverria I; Zettl A; Beà S; Moreno V; Valls J; Hartmann E; Ott G; Wright G; Lopez-Guillermo A; Chan WC; Weisenburger DD; Gascoyne RD; Grogan TM; Delabie J; Jaffe ES; Montserrat E; Muller-Hermelink HK; Staudt LM; Rosenwald A; Campo E
    J Clin Oncol; 2007 Apr; 25(10):1216-22. PubMed ID: 17296973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.